# Trade Mark Journal No.2026/032 7 August 2026

## WO0000001918358 (5)

Office of origin: United States of America

Date of International Registration:19 March 2026
Date of designation in the UK: 19 March 2026

International priority date claimed: 17 November 2025 (United States of America) (99501029)

Class 5
  Pharmaceutical preparations for the treatment and prevention of diseases, namely, human metabolic diseases, human neurological diseases, human ophthalmological diseases, and human genetic diseases.

Insitro, Inc.

Representative: Abion UK Limited, The Forum, St Paul's, 33 Gutter Lane London EC2V 8AS UNITED KINGDOM